Ventyx Biosciences, Inc. (VTYX)
14.00
+0.02 (0.14%)
Inactive · Last trade price
on Mar 3, 2026
Ventyx Biosciences Employees
Ventyx Biosciences had 82 employees as of December 31, 2024. The number of employees increased by 2 or 2.50% compared to the previous year.
Employees
82
Change (1Y)
2
Growth (1Y)
2.50%
Revenue / Employee
n/a
Profits / Employee
-$1,284,422
Market Cap
1.00B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 82 | 2 | 2.50% |
| Dec 31, 2023 | 80 | 21 | 35.59% |
| Dec 31, 2022 | 59 | 32 | 118.52% |
| Dec 31, 2021 | 27 | - | - |
VTYX News
- 6 weeks ago - Halper Sadeh LLC Encourages VTYX and SNCY Shareholders to Contact the Firm to Discuss Their Rights - GlobeNewsWire
- 2 months ago - SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Ventyx Biosciences, Inc. (VTYX) - Newsfile Corp
- 2 months ago - Eli Lilly to buy Ventyx Biosciences in $1.2 billion deal - Reuters
- 2 months ago - Lilly to acquire Ventyx Biosciences to advance oral therapies targeting inflammatory-mediated diseases - PRNewsWire
- 2 months ago - Lilly in talks to buy Ventyx Biosciences in more than $1 billion deal, WSJ reports - Reuters
- 2 months ago - Eli Lilly is in advanced talks to acquire Ventyx Biosciences for more than $1 billion, according to people familiar with the matter - WSJ
- 3 months ago - Ventyx Provides Clinical and Corporate Updates - GlobeNewsWire
- 3 months ago - Ventyx Biosciences to Participate in the Piper Sandler 37th Annual Healthcare Conference - GlobeNewsWire